Top 10 Biomarker Validation and Testing Market Companies to Watch Post-COVID

Posted on Jan 14 2022 6:11 AM

"The major companies in the global biomarkers validation and testing market report include LGC Limited, SGS SA, BiomarkerBay B. V, Intertek Group plc, Eurofins Central Laboratory, AnyGenes, NeoGenomics Laboratories, Inc., GP-Bio Inc, Covance Inc., and others."

Global “Biomarker Validation and Testing Market” 2022 research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Biomarker Validation and Testing Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Biomarker Validation and Testing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. Regionally, this report categorizes the production, apparent consumption, export and import of Biomarker Validation and Testing in North America, Europe, China, Japan, Southeast Asia and India.

The Global Biomarker Validation and Testing market 2022 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Biomarker Validation and Testing Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyses their Biomarker Validation and Testing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

Request a Sample Copy of the Research Report:

Research Methodology:

We follow a robust research methodology that involves data triangulation based on top-down, bottom-up approaches, and validation of the estimated market numbers through primary research. The information used to estimate the market size and forecast for various segments at the global, regional, and country-level is derived from the most credible published sources and through interviews with the right stakeholders.

The Growth rate or CAGR exhibited by a market for a certain forecast period is calculated on the basis of various factors and their level of impact on the market. These factors include market drivers, restraints, industry challenges, market and technological developments, market trends, etc.

Market Segmentation:

By technique, the market is segmented into biomarker immunoassays, flow cytometry and others. Based on applications, the market is segmented into oncology, drug discovery & development and others. Based on end-users, the Biomarkers Validation and Testing Marketis segmented into pharmaceutical & biotechnology companies, research institutes & CRO’s and others.

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Players Covered:

The major companies in the global biomarkers validation and testing market report include LGC Limited, SGS SA, BiomarkerBay B. V, Intertek Group plc, Eurofins Central Laboratory, AnyGenes, NeoGenomics Laboratories, Inc., GP-Bio Inc, Covance Inc., and others.

Key Insights:

  • Overview of Regulatory Scenario in the Biomarker Validation and Testing Market
  • Technological Advancements in the Biomarker Validation and Testing Market
  • Key Mergers and Acquisitions

Regional Analysis:

Geographically the global biomarker validation and testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among the regions, North America accounted for the largest share of the global biomarkers validation and testing market in 2018. The leading position is attributable to the high investments in research and development of the biomarkers, increasing prevalence of cancer, and adoption of personalized medicine by patient pool. Asia Pacific region is anticipated grow at a higher CAGR owing to rise in cancer diagnostic test by patients, need for accurate diagnostics and validation of assays for drug development and discovery as well as strong government backup and funding to launch novel drugs in the market. Latin America and Middle East & Africa are expected to have slower market growth owing to less R&D investments and lack of awareness for technological advancements.

Biomarker Validation and Testing Industry Developments

  • In November 2019, Biocept Inc. launched a liquid biopsy test TARGET SELECTOR, a pan-TRK assay for the detection of TRK proteins designed to provide physicians with presence of NTRK fusions in patients diagnosed with cancer.
  • In October 2019, Biocartis Group NV announced the launch of IDYLLA ctEGFR Mutation Assay. The liquid biopsy assay provides accurate and highly molecular information of 49 EGFR mutations from blood plasma of a cancer patient.
  • In May 2019, Roche launched VENTANA HER2 Dual ISH DNA Probe Cocktail assay, to detect HER2 biomarker found in the gastric cancers.
  • In May 2019, QIAGEN announced the launch of therascreen PIK3CA RGQ PCR Kit. The USFDA approved kit is useful in detection of activating mutations of PIK3CA gene in any cancer indications.

Market Segmentation:

By Technique   

  • Biomarker Immunoassays
  • Flow Cytometry
  • Others

By Applications

  • Oncology
  • Drug Discovery & Development
  • Others

By End-user       

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes & CRO’s
  • Others

By Geography  

  • c

Have Any Query? Ask Our Experts:

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Fortune Business Insights™

LinkedIn | Twitter | Blogs